Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking

Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking

<p>Abstract</p> <p>Background</p> <p>Estimates of the risk of developing Crohn's disease (CD) can be made using DNA testing for mutations in the NOD2 (CARD15) gene, family history, and smoking status. Smoking doubles the risk of CD, a risk that is reduced by stoppi...

Full description

Bibliographic Details
Main Authors: Armstrong David, Prevost A Toby, Hollands Gareth J, Sanderson Jeremy, Watts Sally, Forbes Alastair, Lewis Cathryn M, Mathew Christopher G, Whitwell Sophia CL, Kinmonth Ann, Sutton Stephen, Marteau Theresa M
Format: Article
Language:English
Published: BMC 2011-01-01
Series:BMC Public Health
Online Access:http://www.biomedcentral.com/1471-2458/11/44

Internet

http://www.biomedcentral.com/1471-2458/11/44

Similar Items